vs
Side-by-side financial comparison of Quest Diagnostics (DGX) and PAN AMERICAN SILVER CORP (PAAS). Click either name above to swap in a different company.
Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $2.8B, roughly 1.0× PAN AMERICAN SILVER CORP).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Pan American Silver Corporation is a mining company based in Canada with operations in Latin America. The company has mines and other projects in Mexico, Peru, Bolivia, and Argentina.
DGX vs PAAS — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2022
| Metric | | |
|---|---|---|
| Revenue | $2.9B | $2.8B |
| Net Profit | $281.0M | — |
| Gross Margin | — | 27.0% |
| Operating Margin | 15.4% | — |
| Net Margin | 9.7% | — |
| Revenue YoY | 9.2% | — |
| Net Profit YoY | 12.0% | — |
| EPS (diluted) | $2.24 | $-1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.8B | — | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.8B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | $281.0M | — | ||
| Q4 25 | $245.0M | — | ||
| Q3 25 | $245.0M | — | ||
| Q2 25 | $282.0M | — | ||
| Q1 25 | $220.0M | — | ||
| Q4 24 | $222.0M | — | ||
| Q3 24 | $226.0M | — | ||
| Q2 24 | $229.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 32.4% | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 32.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 32.6% | — | ||
| Q2 24 | 33.5% | — |
| Q1 26 | 15.4% | — | ||
| Q4 25 | 13.8% | — | ||
| Q3 25 | 13.7% | — | ||
| Q2 25 | 15.9% | — | ||
| Q1 25 | 13.0% | — | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 14.8% | — |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 8.7% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 9.6% | — |
| Q1 26 | $2.24 | — | ||
| Q4 25 | $2.18 | — | ||
| Q3 25 | $2.16 | — | ||
| Q2 25 | $2.47 | — | ||
| Q1 25 | $1.94 | — | ||
| Q4 24 | $1.95 | — | ||
| Q3 24 | $1.99 | — | ||
| Q2 24 | $2.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $393.0M | — |
| Total DebtLower is stronger | $5.7B | — |
| Stockholders' EquityBook value | $7.7B | — |
| Total Assets | $16.7B | — |
| Debt / EquityLower = less leverage | 0.74× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $393.0M | — | ||
| Q4 25 | $420.0M | — | ||
| Q3 25 | $432.0M | — | ||
| Q2 25 | $319.0M | — | ||
| Q1 25 | $188.0M | — | ||
| Q4 24 | $549.0M | — | ||
| Q3 24 | $764.0M | — | ||
| Q2 24 | $271.0M | — |
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.2B | — | ||
| Q3 25 | $5.2B | — | ||
| Q2 25 | $5.2B | — | ||
| Q1 25 | $5.9B | — | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $5.6B | — | ||
| Q2 24 | $3.8B | — |
| Q1 26 | $7.7B | — | ||
| Q4 25 | $7.2B | — | ||
| Q3 25 | $7.3B | — | ||
| Q2 25 | $7.2B | — | ||
| Q1 25 | $6.9B | — | ||
| Q4 24 | $6.8B | — | ||
| Q3 24 | $6.8B | — | ||
| Q2 24 | $6.6B | — |
| Q1 26 | $16.7B | — | ||
| Q4 25 | $16.2B | — | ||
| Q3 25 | $16.2B | — | ||
| Q2 25 | $16.0B | — | ||
| Q1 25 | $15.8B | — | ||
| Q4 24 | $16.2B | — | ||
| Q3 24 | $16.1B | — | ||
| Q2 24 | $13.9B | — |
| Q1 26 | 0.74× | — | ||
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 0.83× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.58× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 3.9% | — |
| Cash ConversionOCF / Net Profit | 0.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $278.0M | — | ||
| Q4 25 | $465.0M | — | ||
| Q3 25 | $563.0M | — | ||
| Q2 25 | $544.0M | — | ||
| Q1 25 | $314.0M | — | ||
| Q4 24 | $464.0M | — | ||
| Q3 24 | $356.0M | — | ||
| Q2 24 | $360.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $307.0M | — | ||
| Q3 25 | $419.0M | — | ||
| Q2 25 | $436.0M | — | ||
| Q1 25 | $197.0M | — | ||
| Q4 24 | $341.0M | — | ||
| Q3 24 | $250.0M | — | ||
| Q2 24 | $268.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 7.4% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 11.2% | — |
| Q1 26 | 3.9% | — | ||
| Q4 25 | 5.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 3.8% | — |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.90× | — | ||
| Q3 25 | 2.30× | — | ||
| Q2 25 | 1.93× | — | ||
| Q1 25 | 1.43× | — | ||
| Q4 24 | 2.09× | — | ||
| Q3 24 | 1.58× | — | ||
| Q2 24 | 1.57× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
